Comment. Is incretin-based therapy ready for the care of hospitalized patients with type 2 diabetes?
Corresponding author: Adam M. Deane, adam.deane@adelaide.edu.au.
Adam M
AM
Deane
Michael
M
Horowitz
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D054795:Incretins / Q000627:therapeutic use*; D018027:Receptors, Glucagon / Q000819:agonists*
D054795:Incretins; D018027:Receptors, Glucagon